Biochemical Investigations in the Management of Liver Disease

Textbook of Hepatology: From Basic Science to Clinical Practice, Third Edition

Volumn , Issue , 2008, Pages 451-467

  Rigato, Igino ^a   Donald Ostrow, J ^b   Tiribelli, Claudio ^a  

^a UNIVERSITY OF TRIESTE   (Italy)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Biochemical test; Chronic viral hepatitis; Hepatobiliary diseases; Hepatocellular damage; Plasma membranes

Indexed keywords

EID: 77952681626     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470691861.ch5b     Document Type: Chapter

References (86)

1. Dufour DR, Lott JA, Nolte FS et al. (2000) Diagnosis and monitoring of hepatic injury. II. Recommendations for use of laboratory tests in screening, diagnosis, and monitoring. Clin Chem 46, 2050-2068.
2. Rej R (1989) Aminotransferases in disease. Clin Lab Med 9, 667-687.
3. Rej R (1978) Aspartate aminotransferase activity and isoenzyme proportions in human liver tissues. Clin Chem 24, 1971-1979.
4. Kempe E, Laursen T (1960) Investigations of the excretion of enzymes in urine. Scand J Clin Lab Invest 12, 463-471.
5. Bergmeyer HU, Horder M, Rej R (1986) International Federation of Clinical Chemistry (IFCC) Scientific Committee, Analytical Section: approved recommendation (1985) on IFCC methods for the measurement of catalytic concentration of enzym. Part 3. IFCC method for alanine aminotransferase (l-alanine:2-oxoglutarate aminotransferase, EC 2.6.1.2). J Clin Chem Clin Biochem 24, 481-495.
6. Siest G, Schiele F, Galteau MM et al. (1975) Aspartate aminotransferase and alanine aminotransferase activities in plasma: statistical distributions, individual variations, and reference values. Clin Chem 21, 1077-1087.
7. Gitlin N (1982) The serum glutamic oxaloacetic transaminase/serum glutamic pyruvic transaminase ratio as a prognostic index in severe acute viral hepatitis. Am J Gastroenterol 77, 2-4.
8. Chopra S, Griffin PH (1985) Laboratory tests and diagnostic procedures in evaluation of liver disease. Am J Med 79, 221-230.
9. Sharpe PC (2001) Biochemical detection and monitoring of alcohol abuse and abstinence. Ann Clin Biochem 38, 652-664.
10. Salvaggio A, Periti M, Miano L et al. (1991) Body mass index and liver enzyme activity in serum. Clin Chem 37, 720-723.
11. Warnock LG, Stone WJ, Wagner C (1974) Decreased aspartate aminotransferase ('SGOT') activity in serum of uremic patients. Clin Chem 20, 1213-1216.
12. Wroblewski F (1959) The clinical significance of transaminase activities of serum. Am J Med 27, 911-923.
13. Grimwood K, Coakley JC, Hudson IL et al. (1988) Serum aspartate aminotransferase levels after rotavirus gastroenteritis. J Pediatr 112, 597-600.
14. Dufour DR, Lott JA, Nolte FS et al. (2000) Diagnosis and monitoring of hepatic injury. I. Performance characteristics of laboratory tests. Clin Chem 46, 2027-2049.
15. Panteghini M (1990) Aspartate aminotransferase isoenzymes. Clin Biochem 23, 311-319.
16. Bierman HR, Hill BR, Reinhardt L, Emory E (1957) Correlation of serum lactic dehydrogenase activity with the clinical status of patients with cancer, lymphomas, and the leukemias. Cancer Res 17, 660-667.
17. Peters T Jr (1977) Serum albumin: recent progress in the understanding of its structure and biosynthesis. Clin Chem 23, 5-12.
18. Campbell PN (1975) The biosynthesis of serum albumin. FEBS Lett 54, 119-121.
19. Rothschild MA, Oratz M, Schreiber SS (1988) Serum albumin. Hepatology 8, 385-401.
20. Hill PG (1985) The measurement of albumin in serum and plasma. Ann Clin Biochem 22, 565-578.
21. De Feo P, Lucidi P (2002) Liver protein synthesis in physiology and in disease states. Curr Opin Clin Nutr Metab Care 5, 47-50.
22. Rothschild MA, Oratz M, Schreiber SS (1972) Albumin synthesis (second of two parts). N Engl J Med 286, 816-821.
23. Doweiko JP, Nompleggi DJ (1991) The role of albumin in human physiology and pathophysiology, Part III: Albumin and disease states. J Parenter Enteral Nutr 15, 476-483.
24. Lewith G, Gabriel R (1975) Biochemical anomalies of the nephrotic syndrome. Curr Med Res Opin 3, 199-202.
25. Murch S (2005) Protein-losing disorders of the gastrointestinal tract. In: Wilfred M, Weinstein CJ, Bosch J (eds) Clinical Gastroenterology and Hepatology. London: Elsevier Mosby, pp. 309-314.
26. Kim GH, Oh KH, Yoon JW et al. (2003) Impact of burn size and initial serum albumin level on acute renal failure occurring in major burn. Am J Nephrol 23, 55-60.
27. Walls WD, Losowsky MS (1971) The hemostatic defect of liver disease. Gastroenterology 60, 108-119.
28. Quick AJ (1949) The coagulation mechanism, with specific reference to the interpretation of prothrombin time and a consideration of the prothrombin consumption time. Am J Clin Pathol 19, 1016-1023.
29. Baglin T, Luddington R (1997) Reliability of delayed INR determination: implications for decentralized anticoagulant care with off-site blood sampling. Br J Haematol 96, 431-434.
30. Munoz SJ (1991) Prothrombin time in fulminant hepatic failure. Gastroenterology 100, 1480-1481.
31. Roberts HR, Cederbaum AI (1972) The liver and blood coagulation: physiology and pathology. Gastroenterology 63, 297-320.
32. Rybak M, Dyrhon V, Losticky C et al. (1988) Effect of liver damage on the level of coagulation factor II, X and VII in human and bovine plasma. Thromb Res 52, 79-85.
33. Eisenberg JM, Goldfarb S (1976) Clinical usefulness of measuring prothrombin time as a routine admission test. Clin Chem 22, 1644-1647.
34. Roberts HR, Stinchcombe TE, Gabriel DA (2001) The dysfibrinogenaemias. Br J Haematol 114, 249-257.
35. de Maat MP, Nieuwenhuizen W, Knot EA et al. (1995) Measuring plasma fibrinogen levels in patients with liver cirrhosis. The occurrence of proteolytic fibrin(ogen) degradation products and their influence on several fibrinogen assays. Thromb Res 78, 353-362.
36. Izumi S, Hughes RD, Langley PG et al. (1994) Extent of the acute phase response in fulminant hepatic failure. Gut 35, 982-986.
37. Mammen EF (1994) Coagulation defects in liver disease. Med Clin North Am 78, 545-554.
38. Coccheri S, Mannucci PM, Palareti G et al. (1982) Significance of plasma fibrinopeptide A and high molecular weight fibrinogen in patients with liver cirrhosis. Br J Haematol 52, 503-509.
39. Ballmer PE, Reichen J, McNurlan MA et al. (1996) Albumin but not fibrinogen synthesis correlates with galactose elimination capacity in patients with cirrhosis of the liver. Hepatology 24, 53-59.
40. Rustemeijer C, Schouten JA, Voerman HJ et al. (2001) Is pseudocholinesterase activity related to markers of triacylglycerol synthesis in Type II diabetes mellitus? Clin Sci (Lond) 101, 29-35.
41. Sanz P, Rodriguez-Vicente MC, Diaz D et al. Red blood cell and total blood acetylcholinesterase and plasma pseudocholinesterase in humans: observed variances. J Toxicol Clin Toxicol 29, 81-90.
42. Breen KJ, Schenker S (1971) Liver function tests. CRC Crit Rev Clin Lab Sci 2, 573-599.
43. Wilson A, Calvert RJ, Geoghegan H (1952) Plasma cholinesterase activity in liver disease: its value as a diagnostic test of liver function compared with flocculation tests and plasma protein determinations. J Clin Invest 31, 815-823.
44. Viby-Mogensen J, Hanel HK, Hansen E et al. (1975) Serum cholinesterase activity in burned patients. I: biochemical findings. Acta Anaesthesiol Scand 19, 159-168.
45. Butterworth RF (2000) Complications of cirrhosis III. Hepatic encephalopathy. J Hepatol 32(1 Suppl.), 171-180.
46. Lockwood AH (2004) Blood ammonia levels and hepatic encephalopathy. Metab Brain Dis 19, 345-349.
47. Simon JB, Poon RW (1978) Lipoprotein-X levels in extrahepatic versus intrahepatic cholestasis. Gastroenterology 75, 177-180.
48. Miller JP (1990) Dyslipoproteinaemia of liver disease. Baillières Clin Endocrinol Metab 4, 807-832.
49. Szalay F (2001) Treatment of primary biliary cirrhosis. J Physiol Paris 95, 407-412.
50. Baraona E, Lieber CS (1979) Effects of ethanol on lipid metabolism. J Lipid Res 20, 289-315.
51. Rigato I, Ostrow JD, Tiribelli C (2005) Bilirubin and the risk of common non-hepatic diseases. Trends Mol Med 11, 277-283.
52. Persico M, Persico E, Bakker CT et al. (2001) Hepatic uptake of organic anions affects the plasma bilirubin level in subjects with Gilbert's syndrome mutations in UGT1A1. Hepatology 33, 627-632.
53. Paulusma CC, Kothe MJ, Bakker CT et al. (2000) Zonal downregulation and redistribution of the multidrug resistance protein 2 during bile duct ligation in rat liver. Hepatology 31, 684-693.
54. Gambino R (1965) Bilirubin (modified Jendrassik and Grof). In: Meites S (ed.) Standard Methods of Clinical Chemistry. New York and London: Academic Press, pp. 55-64.
55. Richterich R (1969) Total bilirubin in the newborn: direct spectrophotometry. In: Karger S. (ed.) Clinical Chemistry. Theory and Practice. New York and London: Academic Press, pp. 416-418.
56. Blanckaert N, Kabra PM, Farina FA et al. (1980) Measurement of bilirubin and its monoconjugates and diconjugates in human serum by alkaline methanolysis and high-performance liquid chromatography. J Lab Clin Med 96, 198-212.
57. Lumeng L, O'Connor K (1986) Differential diagnosis of jaundice. In: Ostrow JD (ed.) From Bile Pigments to Jaundice. New York: Marcell Dekker, pp. 475-538.
58. Cekic D, Rigato I, Tiribelli C (2005) Disturbances of bilirubin metabolism. In: Weinstein WM, Hawkey CJ, Bosch J (eds) Clinical Gastroenterology and Hepatology. London: Elsevier Mosby, pp. 693-698.
59. Christensen E, Bremmelgaard A, Bahnsen M et al. (1984) Prediction of fatality in fulminant hepatic failure. Scand J Gastroenterol 19, 90-96.
60. Neuberger J (1997) Transplantation for primary biliary cirrhosis. Semin Liver Dis 17, 137-146.
61. Van Hoof VO, De Broe ME (1994) Interpretation and clinical significance of alkaline phosphatase isoenzyme patterns. Crit Rev Clin Lab Sci 31, 197-293.
62. Hagerstrand I (1975) Distribution of alkaline phosphatase activity in healthy and diseased human liver tissue. Acta Pathol Microbiol Scand [A] 83, 519-526.
63. Kaplan MM (1972) Alkaline phosphatase. Gastroenterology 62, 452-468.
64. Whitfield JB, Pounder RE, Neale G, Moss DW (1972) Serum-glutamyl transpeptidase activity in liver disease. Gut 13, 702-708.
65. Cherian AG, Hill JG (1978) Age dependence of serum enzymatic activities (alkaline phosphatase, aspartate aminotransferase, and creatine kinase) in healthy children and adolescents. Am J Clin Pathol 70, 783-789.
66. Bennett DL, Ward MS, Daniel WA Jr (1976) The relationship of serum alkaline phosphatase concentrations to sex maturity ratings in adolescents. J Pediatr 88, 633-636.
67. Eastman JR, Bixler D (1977) Serum alkaline phosphatase: normal values by sex and age. Clin Chem 23, 1769-1770.
68. Hsu SH, Tsai KS (1997) Different age-related trends of bone and nonbone forms of alkaline phosphatase in Chinese men and women. Clin Chem 43, 186-188.
69. Hatoff DE, Hardison WG (1979) Induced synthesis of alkaline phosphatase by bile acids in rat liver cell culture. Gastroenterology 77, 1062-1067.
70. Kaplan MM (1972) Alkaline phosphatase. N Engl J Med 286, 200-202.
71. Schaefer J, Schiff L (1965) Liver function tests in metastatic tumor of the liver: study of 100 cases. Gastroenterology 49, 360-363.
72. Breen KJ, Schenker S (1971) Liver function tests. CRC Crit Rev Clin Lab Sci 2, 573-599.
73. Sher PP (1982) Drug interference with clinical laboratory tests. Drugs 24, 24-63.
74. Wilson JW (1979) Inherited elevation of alkaline phosphatase activity in the absence of disease. N Engl J Med 301, 983-984.
75. Jacobs WL (1972) Gamma-glutamyl-transpeptidase in diseases of the liver, cardiovascular system and diabetes mellitus. Clin Chim Acta 38, 419-434.
76. Szasz G (1969) A kinetic photometric method for serum gammaglutamyl transpeptidase. Clin Chem 15, 124-136.
77. Schiele F, Guilmin AM, Detienne H, Siest G (1977) Gammaglutamyltransferase activity in plasma: statistical distributions, individual variations, and reference intervals. Clin Chem 23, 1023-1028.
78. Whitfield JB (2001) Gamma glutamyl transferase. Crit Rev Clin Lab Sci 38, 263-355.
79. Lum G, Gambino SR (1972) Serum gamma-glutamyl transpeptidase activity as an indicator of disease of liver, pancreas, or bone. Clin Chem 18, 358-362.
80. Cooper EH, Turner R, Steele L et al. (1975) The contribution of serum enzymes and carcinoembryonic antigen to the early diagnosis of metastatic colorectal cancer. Br J Cancer 31, 111-117.
81. Braide SA, Davies TJ (1987) Factors that affect the induction of gamma glutamyltransferase in epileptic patients receiving anti-convulsant drugs. Ann Clin Biochem 24, 391-399.
82. Nagaya T, Yoshida H, Takahashi H et al. (1999) Dose-response relationships between drinking and serum tests in Japanese men aged 40-59 years. Alcohol 17, 133-138.
83. Lamy J, Baglin MC, Aron E, Weill J (1975) Decrease in serum gamma-glutamyltranspeptidase following abstention from alcohol in cirrhotics. Clin Chim Acta 60, 97-101.
84. Silva IS, Ferraz ML, Perez RM et al. (2004) Role of gamma-glutamyl transferase activity in patients with chronic hepatitis C virus infection. J Gastroenterol Hepatol 19, 314-318.
85. McKenna JP, Moskovitz M, Cox JL (1989) Abnormal liver function tests in asymptomatic patients. Am Fam Physician 39, 117-126.
86. Goldberg DM (1973) 5′-Nucleotidase: recent advances in cell biology, methodology and clinical significance. Digestion 8, 87-99.